Clinical Research Directory
Browse clinical research sites, groups, and studies.
Stroke Prevention In Ischemic Stroke With Covert Atrial Fibrillation
Sponsor: Assistance Publique - Hôpitaux de Paris
Summary
Patients who have recently had an ischemic stroke with no clear cause might have undetected atrial fibrillation (AF) that isn't caught during their initial hospital stay. After discharge, these patients are typically monitored for AF using devices like Holter monitors or implantable loop recorders. Treatment options during this period include anticoagulants or aspirin. Anticoagulants are more effective in preventing recurrent strokes if AF is present, offering an 80% risk reduction compared to aspirin's 20%. If AF is detected, anticoagulant treatment continues; if not, patients may switch to aspirin after 6-12 months. Despite the clinical rationale for using anticoagulants during this search period, their benefit-risk ratio compared to aspirin has not been fully evaluated.
Key Details
Gender
All
Age Range
65 Years - Any
Study Type
INTERVENTIONAL
Enrollment
1148
Start Date
2024-09-01
Completion Date
2028-03-01
Last Updated
2024-07-05
Healthy Volunteers
No
Interventions
Apixaban
Patients who have had an ischemic stroke will receive either an anticoagulant or aspirin according to their randomization arm.
Aspirin
Aspirin is used as the standard of care